HKI-272-来那替尼 Neratinib_JAK/STAT 信号通路-MedChemExpress LLC

联系我们时请说明是91化工仪器网上看到的信息，谢谢!

产品简介 品牌 MedChemExpress (MCE) 货号 HY-32721 规格 10 mM * 1 mL；5 mg；10 mg 供货周期 现货 应用领域 生物产业     Neratinib 是一种可口服的，不可逆的 tyrosine kinase 抑制剂，能够抑制 HER2 和 EGFR 的活性，IC50 值分别为 59 nM 和 92 nM。
详细介绍 Neratinib

产品活性：Neratinib 是一种可口服的，不可逆的 tyrosine kinase 抑制剂，能够抑制 HER2 和 EGFR 的活性，IC50 值分别为 59 nM 和 92 nM。

研究领域：JAK/STAT Signaling | Protein Tyrosine Kinase/RTK

作用靶点：EGFR

In Vitro: Neratinib has inhibition of tyrosine kinases KDR and Src with IC50 of 0.8 μM and 1.4 μM, respectively, being 14- and 24-fold less active compared with HER2. Neratinib displays no activity against other serine-threonine kinases such as Akt, cyclin D1/cdk4, cyclin E/cdk2, cyclin B1/cdk1, IKK-2, MK-2, PDK1, c-Raf, and Tpl-2, as well as the tyrosine kinase c-Met. Neratinib selectively inhibits the proliferation of 3T3 cells transfected with the HER2 (3T3/neu), as well as two other HER-2-overexpressing SK-Br-3 and BT474 cells with IC50 values of 2-3 nM, displaying > 230-fold potency compared with non-transfected 3T3 cells as well as MDA-MB-435 and SW620 which are EGFR- and HER2-negative. Neratinib also inhibits the proliferation of EGFR-dependent A431 cells with an IC50 of 81 nM. Neratinib reduces HER2 receptor autophosphorylation in BT474 cells with an IC50 of 5 nM, and EGF-dependent phosphorylation of EGFR in A431 cells with IC50 of 3 nM. Blocking of HER-2 by Neratinib results in inhibition of downstream MAPK and Akt pathways with IC50 of 2 nM, more potently than Trastuzumab. Neratinib inhibits the cyclin D1 expression and the phosphorylation of the Rb-susceptibility gene production in BT474 cells with IC50 of 9 nM, leading to G1-S arrest and ultimately decreased cell proliferation.

In Vivo: Orally treated neratinib significantly inhibits the growth of 3T3/neu xenografts, with inhibition of 34%, 53%, 98%, and 98% at dose of 10, 20, 40, and 80 mg/kg/day, respectively. Consistent with the inhibition of HER-2 phosphorylation by 84% within 1 hour of administration at 40 mg/kg/day, Neratinib inhibits the growth of BT474 xenografts by 70-82%, 67%, and 93% at dose of 5, 10, and 40 mg/kg/day, respectively. Neratinib is also effective against SK-OV-3 xenografts with inhibition of 31% and 85% at 5 and 60 mg/kg/day, respectively. Neratinib is less potent against EGFR-dependent A431 xenografts than HER-2-dependent tumors, with 32% and 44% inhibition at 5 and 20 mg/kg/day, respectively. Neratinib displays little activity against MCF-7 and MX-1 xenografts expressing low levels of HER-2 and EGFR, with only 28% inhibition at 80 mg/kg/day, suggesting that Neratinib has selective activity for cells expressing HER-2 or EGFR.

相关产品：Drug Repurposing Compound Library | Kinase Inhibitor Library | JAK/STAT Compound Library | Clinical Compound Library | Clinical Compound Library Plus | Protein Tyrosine Kinase Compound Library | Anti-Cancer Compound Library | Drug Repurposing Compound Library Plus | Bioactive Compound Library Plus | Osimertinib | Gefitinib | Afatinib | Erlotinib | AG-490 | Lapatinib | Trastuzumab | Cetuximab | (-)-Epigallocatechin Gallate | Genistein | Dacomitinib | AG-1478 | Poziotinib | Sapitinib | Tucatinib | Pyrotinib | BMS-690514 | TAS6417 | Mubritinib | Olmutinib | Canertinib dihydrochloride | Icotinib | AZD3759 | Tyrphostin 23 | Pelitinib

以上信息由企业自行提供，信息内容的真实性、准确性和合法性由相关企业负责，91化工仪器网对此不承担任何保证责任。
温馨提示：为规避购买风险，建议您在购买产品前务必确认供应商资质及产品质量。 搜本商铺 或 搜全站

MedChemExpress LLC - 主营产品： 西罗莫司 Rapamycin,瑞沙托维 TAK-242,奥拉帕尼 Olaparib

地址：上海市浦东新区张衡路1999弄3号楼      联系电话：86-021-58955995      手机：18019480960     传真：86-021-53700325
91化工仪器网 设计制作，未经允许翻录必究 .      Copyright(C) http://www.chem17.com,      All rights reserved. 以上信息由企业自行提供，信息内容的真实性、准确性和合法性由相关企业负责，91化工仪器网对此不承担任何保证责任。
温馨提示：为规避购买风险，建议您在购买产品前务必确认供应商资质及产品质量。
会员登录